GSK: Meet the Experts - Genetic architecture of Steatotic Liver Disease (Complete Session) - EASL Congress 2024
View
Viral Hepatitis
1
GSK: Time to rethink chronic hepatitis B: A roadmap to functional cure (Complete Session) - EASL Congress 2024
View
Viral Hepatitis
1
GSK: Time to rethink chronic hepatitis B: Quantitative hepatitis B surface antigen today and tomorrow (Complete Session) - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
1
GSK: Unlocking the genetic architecture of Steatotic Liver Disease. A new paradigm in patient management (Complete Session) - EASL Congress 2024
View
Liver Tumours
6
Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024
View
Liver Tumours
6
Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024
View
Liver Tumours
6
Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024
View
Liver Tumours
6
Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024
View
Liver Tumours
6
Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024
View
Liver Tumours
6
Bayer: Evolving horizons in HCC diagnosis and therapy - EASL Liver Cancer Summit 2024
View
Liver Tumours
6
Bayer: Advancements in MRI for imaging assessment of HCC: Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023
View
Liver Tumours
6
Bayer: Advancements in MRI for imaging assessment of HCC: Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023
